Geneos Wealth Management’s GCP Applied Technologies Inc. GCP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-302
Closed -$9K 2720
2022
Q2
$9K Hold
302
﹤0.01% 2019
2022
Q1
$9K Hold
302
﹤0.01% 2152
2021
Q4
$9K Hold
302
﹤0.01% 2249
2021
Q3
$6K Hold
302
﹤0.01% 2424
2021
Q2
$7K Hold
302
﹤0.01% 2359
2021
Q1
$7K Hold
302
﹤0.01% 2567
2020
Q4
$7K Hold
302
﹤0.01% 2393
2020
Q3
$6K Hold
302
﹤0.01% 2149
2020
Q2
$5K Hold
302
﹤0.01% 2182
2020
Q1
$4K Sell
302
-40
-12% -$848 ﹤0.01% 2140
2019
Q4
$7K Buy
+342
New +$7.36K ﹤0.01% 2121
2019
Q2
Sell
-40
Closed -$1K 2536
2019
Q1
$1K Buy
+40
New +$1.07K ﹤0.01% 2382
2018
Q4
Sell
-40
Closed -$1K 2511
2018
Q3
$1K Hold
40
﹤0.01% 2395
2018
Q2
$1K Hold
40
﹤0.01% 2242
2018
Q1
$1K Hold
40
﹤0.01% 2150
2017
Q4
$1K Hold
40
﹤0.01% 2153
2017
Q3
$1K Hold
40
﹤0.01% 2102
2017
Q2
$1K Hold
40
﹤0.01% 2053
2017
Q1
$1K Hold
40
﹤0.01% 2043
2016
Q4
$1K Hold
40
﹤0.01% 2028
2016
Q3
$1K Hold
40
﹤0.01% 1953
2016
Q2
$1K Buy
+40
New +$938 ﹤0.01% 1789

Other funds holding GCP

Geneos Wealth Management's GCP Position: Q3 2022 in Review

Geneos Wealth Management sold out of GCP Applied Technologies Inc. (GCP) in Q3 2022, closing a stake of 302 shares — an estimated $9K sold.

Geneos Wealth Management first reported a position in GCP in Q2 2016 and held it in 22 quarters. The position peaked at $9K in Q2 2022. 1 fund tracked by Wall St. Rank holds GCP as of Q3 2022.

  • Geneos Wealth Management reported no remaining GCP Applied Technologies Inc. position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 302 GCP Applied Technologies Inc. shares in Q3 2022, an estimated $9K.
  • Geneos Wealth Management first reported a position in GCP Applied Technologies Inc. in Q2 2016 and held it in 22 quarters.
  • Geneos Wealth Management's GCP Applied Technologies Inc. position peaked at $9K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held GCP Applied Technologies Inc. as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.